Defective Heart Defibrillators recalled by Guidant CorporationWritten by Mike Mahon
On June17, 2005 Guidant Corporation recalled close to 50,000 heart defibrillators worldwide because of potential malfunctions that could cause injury or death. This recall comes in wake of two recent deaths among patients who were implanted with Guidant defibrillators. It is believed that Guidant Corporation failed to inform doctors and patients that defibrillators contained a defect that could cause them to short-circuit. The recalled Guidant defibrillators models include: ·Prizm 2 DR, Model 1861, manufactured on or before April 16, 2002 ·Contak Renewal, Model H135, manufactured on or before August 26, 2004 ·Contak Renewal 2, Model H155, manufactured on or before August 26, 2004 ·Prizm AVT Vitality SVT Renewal 3 ·AVT Renewal 4 AVT On June 24, Guidant issued an advisory concerning these additional defibrillator devices: ·Contak Renewal 3 and 4 ·Renewal 3 and 4 AVT ·Renewal RF Guidant admits that they discovered defect as early as 2002. However, even though they changed manufacturing of devices, they continued to sell defective defibrillators without notifying doctors or patients of defects. Although Guidant has conducted this recall, they have not yet advised whether implanted defibrillators should be replaced. The Food and Drug Administration has advised patients to take following steps: 1.Contact your doctor immediately to determine if your defibrillator is a model being recalled by Guidant. 2.Keep your regularly scheduled doctor appointments. 3.Contact your doctor immediately if you experience an electrical shock from your defibrillator. 4.Contact your doctor immediately if you notice a beeping sound coming from your defibrillator.
| | Zoloft Side Effects: Akathisia and Violent BehaviorWritten by Margaret Wommack
Zoloft is an SSRI (selective serotonin reuptake inhibitor); a prescription drug that combats depression, anxiety, posttraumatic stress disorder (PTSD), panic disorder, obsessive-compulsive disorder (OCD), as well as other various problems. SSRIs work by allowing more serotonin to be released through brain. Seratonin is a brain chemical associated with happiness. Between nerve endings in brain, there are synapses. All signals in brain are transmitted through chemicals being produced then absorbed by one nerve and another. When these chemicals are released they are either taken in by next nerve or nerve that released them will re-absorb them and signal doesn’t pass. Some antidepressants work by blocking reuptake of Seratonin by releasing nerve. That means that more Seratonin stays in synapse in hope that it will be absorbed by new nerve which, in case of Seratonin, would continue signal of happiness.
|
